TOSLA opens Super Factory and new headquarters in Slovenia

TOSLA opened its new Super Factory, TOSLA 3, and its Pavlina headquarters in Ajdovščina, Slovenia, on June 5, 2026, as it expands from nutricosmetics into broader nutraceuticals. The move triples production capacity to as much as 100,000 bottles a day and is designed to speed co-development and market launches for global brands.

Why it matters: - TOSLA’s new manufacturing platform is built to help brands bring liquid nutraceutical products to market faster. - The expansion gives the B Corp certified CDMO more scale, more formulation flexibility and a broader role across beauty, wellness and preventive health. - The company said the new setup supports launches in as little as 60 days.

What happened: - TOSLA officially opened TOSLA 3, described as a Super Factory, and Pavlina, its new headquarters, in Ajdovščina, Slovenia. - The opening event took place on Friday, June 5, 2026, and brought together partners, clients and collaborators. - TOSLA called the milestone a step in its evolution into a full-spectrum nutraceutical partner.

The details: - TOSLA 3 is designed as a next-generation manufacturing facility for liquid nutraceutical innovation. - The plant uses advanced automation, intelligent batching and formulation-driven process design. - TOSLA said the new facility has tripled production capacity to up to 100,000 bottles per day. - The company said quality remains consistent across development and full-scale production. - TOSLA 3 is part of an integrated ecosystem linking R&D, manufacturing and commercial execution. - The company offers white-label and private-label solutions. - TOSLA also provides custom formulation development. - The company handles full in-house production, filling and packaging. - TOSLA supports brands from R&D through market launch. - The company said its innovation model centers on validation, palatability and simplicity. - TOSLA said its R&D library and VELIOUS Flavor Technology support complex, multi-benefit formulations. - Pavlina was designed as a hub for collaboration, product experience and strategic partnerships. - The headquarters includes spaces for tasting, development and creative exchange.

Between the lines: - The expansion signals that TOSLA is moving beyond a contract manufacturer role toward a broader co-development platform. - The focus on scientific rigor plus sensory experience suggests the company is trying to differentiate on both efficacy and consumer appeal. - The shift into the wider nutraceutical category gives TOSLA a larger addressable market than nutricosmetics alone. - CEO Primož Artač said the investment reflects a long-term plan to unite R&D, manufacturing and strategy in one system. - CIO Uroš Gotar said TOSLA 3 is designed to create faster development cycles, greater formulation complexity and more reliable processes for partners.

What’s next: - TOSLA will use the new facilities to scale co-development work with global brands. - The company is positioning itself to support more products across beauty, wellness and preventive health. - The integrated setup should help TOSLA push more launches through shorter development timelines.

The bottom line: - TOSLA is betting that bigger manufacturing capacity, deeper R&D and a more collaborative headquarters will help it win more global nutraceutical business.